Wadie David
Cardiovascular Disease · Southfield, MINPI 1740868272
Payments from drug & device makers
Across 106 payments — averaging $37.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$575
- Abiomed$436
- Chiesi USA, Inc.$395
- Kestra Medical Technology Services, Inc.$382
- Medtronic$338
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$263
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,82696%
- Education$1594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $575 |
| Abiomed | 8 | $436 |
| Chiesi USA, Inc. | 13 | $395 |
| Kestra Medical Technology Services, Inc. | 14 | $382 |
| Medtronic | 5 | $338 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $263 |
| Pfizer | 11 | $247 |
| Amgen | 2 | $245 |
| Inari Medical, Inc. | 2 | $180 |
| Stryker | 2 | $171 |
| Shockwave Medical, Inc | 1 | $153 |
| Merck | 6 | $130 |
| AstraZeneca | 4 | $97 |
| Novartis | 4 | $76 |
| Bayer | 2 | $41 |
| Boehringer Ingelheim | 2 | $38 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $37 |
| United Therapeutics Corporation | 2 | $34 |
| Teleflex LLC | 2 | $33 |
| Reflow Medical Inc | 1 | $24 |
| Heartflow, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $18 |
| GE HealthCare | 1 | $18 |
| Inspiremd Ltd | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,985 in reported general payments places this provider in the 50th percentile of 760 cardiovascular disease providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 22 | $20,566 |
| EliquisApixaban | 20 | $16,689 |
| Prasugrel Hcl | 23 | $889 |
| Atorvastatin Calcium | 33 | $530 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $343 |
| Pantoprazole Sodium | 20 | $314 |
| Carvedilol | 29 | $288 |
| Levothyroxine Sodium | 14 | $209 |
| Metoprolol Succinate | 21 | $166 |
| Losartan Potassium | 23 | $162 |
| ClopidogrelClopidogrel Bisulfate | 17 | $134 |
| Rosuvastatin Calcium | 12 | $123 |
| Furosemide | 14 | $77 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $38 | $20,56622 claims |
| PfizerEliquis | $247 | $16,68920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Southfield
- Herman KadoSouthfield$766K
- Stanley ChetcutiAnn Arbor$4.3M
- Sandeep KhuranaGrandville$2.3M
- Victor MolesAnn Arbor$2.1M
- Jihad MustaphaGrand Rapids$1.9M
- Marschall RungeAnn Arbor$1.8M
- Sara SaberiAnn Arbor$1.6M
- Brian OneillDetroit$1.4M
- Vallerie McLaughlinAnn Arbor$1.4M
- Ahmad MizyedYpsilanti$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.